HES Energy Systems Launches 3-hour Endurance Hydrogen Multi-Rotor, Designed & Built in the USA
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181108005467/en/
(Photo: Business Wire)
Addressing short flight durations is one of the final frontiers in drone technology . HES has a long-standing reputation for producing the world’s lightest and most compact fuel cell systems, which can be as much as 5 times lighter than lithium batteries. Following a first world distance record set in the US by a NASA-backed team from OSU over 10 years ago, HES has been pushing the limits its energy storage technology increasingly further, working from Singapore on various UAV programs and with leading aerospace institutions around the world.
HES is currently capable of over 700Wh/kg system-level specific energy and is working to push this limit even further thanks to a variety of novel technologies.
Now and after many years of work, HES merged its core technologies with a specially adapted multi-rotor design so that flight durations can extend to 3.5 hours, instead of the typical 20-30 minutes when using lithium batteries.
Named HYCOPTER, the resulting hydrogen multi-rotor system will now be able to keep precision cameras and other sensors in the air for much longer, opening up new commercial use cases while reducing operational costs for service providers. HYCOPTER was designed in Austin, Texas where a local production base is being set up.
HYCOPTER includes a new breakthrough 140g pressure regulator capable of reducing hydrogen pressure from 350 bar to 0.5 bar. Other system components include specially designed HES fuel cell stacks capable of generating over 1W per gram.
HYCOPTER can recharge in minutes using bottled industrial-grade hydrogen from local hydrogen suppliers. With further improvements, HYCOPTER-type platforms could also enable product deliveries over much longer distances than are possible today. In the future, long range cargo drones would be deployed from autonomous hydrogen “droneports”.
Versions of HYCOPTER will emerge next in transitional wing VTOL applications, and the same HES core technology is now being scaled up to power manned electric aviation as well as other aerial mobility platforms under discussion with various international aerospace companies.
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Tilaa tiedotteet sähköpostiisi
Haluatko tietää asioista ensimmäisten joukossa? Kun tilaat mediatiedotteemme, saat ne sähköpostiisi välittömästi julkaisuhetkellä. Tilauksen voit halutessasi perua milloin tahansa.
Lue lisää julkaisijalta Business Wire
ResMed’s First Top-of-Head CPAP Mask, AirFit N30i, Now Available across U.S.21.1.2019 17:05 | Tiedote
ResMed (NYSE: RMD, ASX: RMD), today introduced AirFit N30i, its first top-of-head-connected nasal CPAP mask, across the United States, with a newly designed nasal cradle cushion that sits just under the wearer’s nose. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190121005035/en/ AirFit N30i nasal CPAP mask, front view (Photo: Business Wire) The top-of-head connection keeps tubing out of the wearer’s way, letting them move and sleep in any position. The nasal cradle cushion – ResMed’s first – is designed to reduce facial markings and irritation. AirFit N30i is also convenient for equipment providers and sleep labs – it fits 96 percent of PAP users with just two frame sizes and four cushion sizes. How AirFit N30i compares to the market-leading nasal top-of-head mask In side-by-side comparisons, three out of four users preferred AirFit N30i over the other nasal mask with a top-of-head connection. A majority stated they loved
Metabolon Appoints Michael Rasche as President of International Business21.1.2019 16:06 | Tiedote
Metabolon, the world leader in metabolomics, today announced that Michael Rasche joined the company as President of International Business. Michael will report to Rohan Hastie, Metabolon’s President and CEO, and become a member of the corporate executive team. He will lead all of Metabolon's international business activities with a strong focus on customer and team expansion. "We are thrilled to have Michael join the Metabolon team," said Hastie. "Michael brings a wealth of commercial and business experience across multiple areas of life sciences, from Pharma to Diagnostics and Biotech. I know he will make an immediate impact on our existing and future customers." "I am very excited to become part of the Metabolon success story," added Rasche. "I will passionately lead our team to drive accelerated business expansion across all international markets. Our Precision Metabolomics™ technology is delivering biomarker discoveries, innovative diagnostic tests, and groundbreaking data in genom
AMCS Announces Acquisition of Recy Systems21.1.2019 16:00 | Tiedote
AMCS, the world’s leading supplier of integrated software and vehicle technology for the waste and recycling sector, has today announced the acquisition of Germany's leading recycling and waste management software specialist, Recy Systems (Recy). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190121005193/en/ Recy has offices in Germany, U.S., U.K. and Slovakia. Their customers include some of the world’s largest and most complex recycling companies. Overall, the acquisition will add another 600 customers from across Europe, in North America, Asia, and Africa, taking AMCS’ total customer base to over 2400 worldwide. In addition to growing AMCS’ market share in the high-growth German market, the acquisition will support its continued development of a best-in-class global solution for the metal recycling industry. It will also contribute to the development of the company’s platform used by the wider waste, recycling and resour
Anticipation Builds as MWC19 Barcelona Approaches21.1.2019 12:00 | Tiedote
The GSMA today announced final updates for MWC19 Barcelona (formerly Mobile World Congress), including additional keynote speakers, participating companies, programmes and events. Taking place 25-28 February 2019, with events being staged at Fira Gran Via, Fira Montjuïc and La Farga L’Hospitalet, MWC19 Barcelona is set to attract more than 107,000 professionals from over 200 countries and territories. “With the anticipated arrival of 5G, this year’s event is set to be one of the most exciting as the industry convenes to showcase Intelligent Connectivity across new technologies on the brink of reaching millions of people across the world,” said John Hoffman, CEO, GSMA Ltd. “Over the four days of MWC19, attendees will have the opportunity to hear from leaders who are driving innovation and we look forward once again to welcoming the mobile world to Barcelona.” Global Leaders to Keynote The GSMA announced the addition of several new keynote speakers for MWC19 including executives from lea
Vertex Announces European Commission Approval for ORKAMBI® (lumacaftor/ivacaftor) for Treatment of Children with Cystic Fibrosis Aged 2 to 5 Years Old with Most Common Form of the Disease21.1.2019 12:00 | Tiedote
Vertex Pharmaceuticals (Europe) Limited today announced that the European Commission has granted approval of the label extension for ORKAMBI® (lumacaftor/ivacaftor) for the treatment of children with cystic fibrosis (CF) aged 2 to 5 years old who have two copies of the F508del mutation, the most common form of the disease. “Today’s approval by the European Commission brings us one step closer to our goal of bringing treatment to all people living with CF,” said Reshma Kewalramani, MD, Executive Vice President, Global Medicines Development and Medical Affairs and Chief Medical Officer at Vertex. ‘‘By treating the underlying cause of disease early, we can potentially modify its course and offer patients the chance of improved outcomes.’’ The label update is based on data from a Phase 3 open-label safety study in 60 patients that showed treatment with lumacaftor/ivacaftor was generally well tolerated for 24 weeks, with a safety profile in these pediatric patients generally consistent with
B2C2 Launches Streaming OTC Pricing with Point-and-Click Execution21.1.2019 12:00 | Tiedote
B2C2, one of the largest cryptocurrency liquidity providers and the leader in electronic OTC trading, today announced the launch of streaming pricing with point-and-click execution on its OTC platform. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190121005063/en/ Max Boonen, Founder and CEO of B2C2 (Photo: Business Wire) For the first time, B2C2’s clients will be able to view and execute trades on a real-time two-way market, via the firm’s secure web interface. The new functionality allows market participants to easily monitor live pricing in user-defined quantities and execute with the click of a button, as they would on traditional FX trading platforms. The launch rounds out a number of milestones for B2C2 in 2018, including surpassing 2017 peak volumes; rolling out a completely redesigned front-end; forming integration partnerships with the major liquidity hubs; and launching a research offering. Founded in 2015, B2C2 i
Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.Tutustu uutishuoneeseemme